Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00894621Phase 4Unknown
Phase 4, randomised, double-blind trial in Shock comparing Norepinephrine with Placebo (2 arms). Primary endpoints: Hemodynamic parameters at 5 days, Diuresis at 5 days and 1 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00894621.